XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 37 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,908,000 | -51.9% | 682,365 | -35.2% | 0.00% | -50.0% |
| Q4 2020 | $6,048,000 | +40.3% | 1,053,683 | +41.5% | 0.00% | 0.0% |
| Q3 2020 | $4,312,000 | +53800.0% | 744,887 | +24729.6% | 0.00% | – |
| Q2 2020 | $8,000 | -66.7% | 3,000 | -11.4% | 0.00% | – |
| Q4 2019 | $24,000 | +4.3% | 3,385 | +45.0% | 0.00% | – |
| Q3 2019 | $23,000 | -11.5% | 2,335 | +4.1% | 0.00% | – |
| Q2 2019 | $26,000 | +1200.0% | 2,242 | +2285.1% | 0.00% | – |
| Q4 2018 | $2,000 | +100.0% | 94 | +104.3% | 0.00% | – |
| Q3 2018 | $1,000 | – | 46 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|